| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Hunan Er-Kang Pharmaceutical Co. Ltd (SHE: 300267)
300267 Technical Analysis
5
| As on 1st Aug 2025 300267 SHARE Price closed @ 4.24 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 2.59 & Strong Buy for SHORT-TERM with Stoploss of 2.58 we also expect STOCK to react on Following IMPORTANT LEVELS. |
300267SHARE Price
| Open | 4.54 | Change | Price | % |
| High | 4.78 | 1 Day | -0.45 | -9.59 |
| Low | 4.22 | 1 Week | 0.83 | 24.34 |
| Close | 4.24 | 1 Month | 1.21 | 39.93 |
| Volume | 268327882 | 1 Year | 1.28 | 43.24 |
| 52 Week High 4.47 | 52 Week Low 2.06 | ||||
SHE China Most Active Stocks
| 002131 | 3.90 | 1.83% |
| 002437 | 4.04 | 8.89% |
| 300058 | 7.18 | 3.31% |
| 002570 | 7.81 | 2.09% |
| 000813 | 4.70 | -3.09% |
| 300182 | 6.11 | 6.45% |
| 000725 | 4.03 | -0.25% |
| 000558 | 7.37 | 10.00% |
| 002097 | 14.19 | 7.09% |
| 002370 | 7.40 | 9.96% |
SHE China Top Gainers Stocks
SHE China Top Losers Stocks
| 300267 Daily Charts |
300267 Intraday Charts |
Whats New @ Bazaartrend |
300267 Free Analysis |
|
|
300267 Important Levels Intraday
| RESISTANCE | 5.32 |
| RESISTANCE | 4.97 |
| RESISTANCE | 4.76 |
| RESISTANCE | 4.55 |
| SUPPORT | 3.93 |
| SUPPORT | 3.72 |
| SUPPORT | 3.51 |
| SUPPORT | 3.16 |
300267 Forecast August 2025
| 4th UP Forecast | 6.03 |
| 3rd UP Forecast | 5.46 |
| 2nd UP Forecast | 5.1 |
| 1st UP Forecast | 4.75 |
| 1st DOWN Forecast | 3.73 |
| 2nd DOWN Forecast | 3.38 |
| 3rd DOWN Forecast | 3.02 |
| 4th DOWN Forecast | 2.45 |
300267 Weekly Forecast
| 4th UP Forecast | 5.26 |
| 3rd UP Forecast | 4.93 |
| 2nd UP Forecast | 4.73 |
| 1st UP Forecast | 4.53 |
| 1st DOWN Forecast | 3.95 |
| 2nd DOWN Forecast | 3.75 |
| 3rd DOWN Forecast | 3.55 |
| 4th DOWN Forecast | 3.22 |
300267 Forecast2025
| 4th UP Forecast | 9.64 |
| 3rd UP Forecast | 7.91 |
| 2nd UP Forecast | 6.84 |
| 1st UP Forecast | 5.77 |
| 1st DOWN Forecast | 2.71 |
| 2nd DOWN Forecast | 1.64 |
| 3rd DOWN Forecast | 0.57 |
| 4th DOWN Forecast | -1.16 |
Hunan Er-Kang Pharmaceutical Co. Ltd ( SHE China Symbol : 300267 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
300267 Business Profile
Hunan Er-Kang Pharmaceutical Co., Ltd manufactures and sells APIs, finished drug products, and pharmaceutical excipients in China and internationally. Its APIs include glycerin, dilute hydrochloric acid, dihydroxypropyl theophylline, sulbenicillin sodium, calamine powder, sulfadiazine, sulphaguanidine, TMP, and resorcinol. The company's finished drugs primarily include sulbenicillin sodium for injection and compound liquorice tablets. Its conventional pharmaceutical excipients include pharmaceutical glycerin, medicinal ethanol, medicinal propylene glycol, medicinal sodium hydroxide, and sucrose; and new pharmaceutical excipients comprise hydroxypropyl starch empty capsules, hydroxypropyl starch soft capsules, and citrate and its series products. The company was founded in 2003 and is based in Liuyang, China. Address: Liuyang National Economic & Technical Development Zone, Liuyang, China
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service